The estimated Net Worth of Edward Moore Jr. Kennedy is at least 1.28 百万$ dollars as of 9 November 2020. Mr. Kennedy owns over 8,333 units of Arvinas Inc stock worth over 1,063,251$ and over the last 6 years he sold ARVN stock worth over 0$. In addition, he makes 214,236$ as Independent Director at Arvinas Inc.
Sign up
Mr. Kennedy ARVN stock SEC Form 4 insiders trading
Edward has made over 2 trades of the Arvinas Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 8,333 units of ARVN stock worth 199,909$ on 9 November 2020.
The largest trade he's ever made was buying 21,000 units of Arvinas Inc stock on 1 October 2018 worth over 336,000$. On average, Edward trades about 3,259 units every 86 days since 2018. As of 9 November 2020 he still owns at least 42,718 units of Arvinas Inc stock.
You can see the complete history of Mr. Kennedy stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Edward Kennedy biography
Edward Kennedy Jr. is Independent Director of the company. Mr. Kennedy has been a Partner and Member of the Health Care and Life Sciences practice of Epstein Becker & Green, P.C., a law firm with a focus on healthcare and life science, since January 2014. He counsels healthcare companies on the legal, reimbursement, coding and coverage issues facing providers, payers and the life sciences industry. Previously, Mr. Kennedy served as the Co-Founder and President of Marwood Group, a healthcare focused strategic advisory and financial services firm, from January 2001 to December 2013. Mr. Kennedy serves as Board Chair of the American Association of People with Disabilities. He also served as a State Senator in the Connecticut General Assembly from January 2015 to January 2019. Mr. Kennedy holds a J.D. from the University of Connecticut School of Law, an M.E.S. from the Yale School of Forestry and Environmental Studies and a B.A. from Wesleyan University.
What is the salary of Edward Kennedy?
As the Independent Director of Arvinas Inc, the total compensation of Edward Kennedy at Arvinas Inc is 214,236$. There are 14 executives at Arvinas Inc getting paid more, with John Houston having the highest compensation of 5,485,840$.
How old is Edward Kennedy?
Edward Kennedy is 58, he's been the Independent Director of Arvinas Inc since 2018. There are 7 older and 10 younger executives at Arvinas Inc. The oldest executive at Arvinas Inc is Laurie Smaldone Alsup, 66, who is the Independent Director.
What's Edward Kennedy's mailing address?
Edward's mailing address filed with the SEC is C/O ARVINAS, INC., 5 SCIENCE PARK, 395 WINCHESTER AVE., NEW HAVEN, CT, 06511.
Insiders trading at Arvinas Inc
Over the last 6 years, insiders at Arvinas Inc have traded over 123,187,141$ worth of Arvinas Inc stock and bought 3,567,290 units worth 69,124,444$ . The most active insiders traders include Capital Management, L.P.Ra ...、Liam Ratcliffe、Kush Parmar. On average, Arvinas Inc executives and independent directors trade stock every 22 days with the average trade being worth of 1,884,820$. The most recent stock trade was executed by John G Houston on 23 February 2024, trading 5,196 units of ARVN stock currently worth 244,472$.
What does Arvinas Inc do?
arvinas is a pharmaceutical company focused on developing new small molecules ‒ known as protacs (proteolysis targeting chimeras) ‒ aimed at degrading disease-causing cellular proteins via proteolysis. based on innovative research conducted at yale university by dr. craig crews, founder and chief scientific advisor, the company is translating natural protein degradation approaches into novel drugs for the treatment of cancer and other diseases. the proprietary protac-based drug paradigm induces protein degradation, rather than protein inhibition, using the ubiquitin proteasome system and offers the advantage of potentially targeting “undruggable” as well as “druggable” elements of the proteome. this greatly expands the ability to create drugs for many new, previously unapproachable targets. for more information, visit www.arvinas.com.
What does Arvinas Inc's logo look like?
Complete history of Mr. Kennedy stock trades at Arvinas Inc
Arvinas Inc executives and stock owners
Arvinas Inc executives and other stock owners filed with the SEC include:
-
John Houston,
President, Chief Executive Officer, Director -
Sean Cassidy,
Chief Financial Officer -
Ian Taylor,
Chief Scientific Officer -
Ronald Peck,
Chief Medical Officer -
Dr. John G. Houston Ph.D.,
CEO, Pres & Director -
Dr. Ronald A. Peck,
Chief Medical Officer -
Dr. Ian Taylor Ph.D.,
Chief Scientific Officer -
Sean A. Cassidy CPA, M.B.A., CPA,
CFO & Treasurer -
Laurie Smaldone Alsup,
Independent Director -
Leslie Norwalk,
Independent Director -
Timothy Shannon,
Independent Chairman of the Board -
Bradley Margus,
Independent Director -
Briggs Morrison,
Independent Director -
Liam Ratcliffe,
Independent Director -
Edward Kennedy,
Independent Director -
Wendy Dixon,
Director -
Linda Bain,
Director -
Steve Weiss,
VP of HR -
Dr. Randy Teel Ph.D.,
Sr. VP of Corp. & Bus. Devel. -
Dr. Robert Kleinfield,
Chief Devel. Officer -
Matthew Batters J.D.,
Gen. Counsel -
Jeff Boyle,
VP of Investor Relations -
Dr. Craig M. Crews,
Founder, Chief Scientific Advisor & Member of Scientific Advisory Board -
Ventures Iii, L.P.5 Am Part...,
-
David K Loomis,
Chief Accounting Officer -
Sunil Agarwal,
Director -
Ix L.P.Canaan Partners Ix L...,
-
Capital Management, L.P.Ra ...,
-
Jakob Loven,
Director -
Andrew Crew,
See Remarks -
Ventures Iii, L.P.5 Am Co I...,
-
James E Deerfield Mgmt L.P....,
-
Craig Martin Crews,
10% owner -
Kush Parmar,
Director -
Angela M Cacace,
Chief Scientific Officer -
John D Young,
Director -
Everett Cunningham,
Director -
Noah Berkowitz,
Chief Medical Officer -
Randy Teel,
Int. Chief Financial Officer